Molecular dynamic simulation of complex NS2B-NS3 DENV2 protease with potential inhibitors of cyclic tripeptide by Tambunan, Usman Sumo Friend et al.
 
 
 
 
Vol. 12(28), pp. 4419-4431, 10 July, 2013  
DOI: 10.5897/AJB2013.12226 
ISSN 1684-5315 ©2013 Academic Journals  
http://www.academicjournals.org/AJB 
African Journal of Biotechnology 
 
 
 
 
 
Full Length Research Paper 
 
Molecular dynamic simulation of complex NS2B-NS3 
DENV2 protease with potential inhibitors of  
cyclic tripeptide 
 
Usman Sumo Friend Tambunan*, Irwan Kurniawan and Arli Aditya Parikesit 
 
Department of Chemistry, Faculty of Mathematics and Science, University of Indonesia Depok 16424, Indonesia. 
 
Accepted 5 July, 2013 
 
The pathogenic dengue virus (DV) is a growing global threat for which there is no specific treatment 
and prevention. Several vaccines have been developed against the disease, but they only prevent the 
disease and reduce the risk of death. Consequently, the antiviral drug becomes the most powerful 
treatment to solve this problem. The virus possesses a two component NS2B-NS3 protease that cleaves 
viral precursor proteins, and therefore represents a target for the development of antiviral drugs. In 
many researches, several models of peptides inhibitor were generated in complexes with the NS2B-NS3 
DENV2 protease by performing molecular docking. The goal of this research was to study the 
interaction of ligands as inhibitors for protein (enzyme) in solvent explicit condition by performing 
molecular dynamics simulation at 300 and 312 K. The simulations were performed on four disulfide 
cyclic tripeptide ligands (RGR, KRK, RRA and RKR) and two proline-proline based cyclic peptide 
ligands (RKK and KKR) compared with linear peptide inhibitor Bz-Nle-K-R-R-H as standard ligand. The 
results provide conformational changes of enzyme-inhibitor complex that is shown by root-mean-
square deviation (RMSD) values. These results show that dynamic behavior of the complex occurs in 
the presence of solvent. The interaction between ligand and amino acid residue of enzyme changed 
during simulation. By these parameters, RKR becomes the best ligand compared with others. The 
ligand has hydrogen bond interaction with the residue of active side, and is stable during simulation at 
both temperatures. In conclusion, RKR ligand is proposed as an antiviral drug by performing molecular 
dynamics simulation. 
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INTRODUCTION 
 
Dengue fever is a disease caused by dengue viruses that 
infect humans and has been affecting a significant 
majority of the world's population (WHO, 2010). Dengue 
virus (DENVs) comes from the family Flaviviridae, and 
genus Flavivirus (Tomlinson et al., 2009). Dengue virus is 
transmitted by Aedes mosquitoes through their bites. 
Female mosquito Aedes aegypti and Aedes albopictus 
are major vectors of dengue virus. Based on sequence 
similarities and differences in antigenic properties, this 
virus has four serotypes, namely: DENV-1, DENV-2, 
DENV-3 and DENV-4 (Lescar et al., 2008). Infection by 
one of these serotypes cannot protect against other 
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serotypes infection, but may increase the pathogenicity of 
subsequent infection by the three other serotypes 
(Tomlinson et al., 2009). Intial infection of dengue virus 
has caused the death rate of about 5%, and increase to 
40% if a virus infection continues to progress until the 
dengue shock syndrome (DSS) (Tambunan et al., 2009). 
Currently, available treatment is only to reduce symptoms 
and the risk of death. Therefore, antiviral medication 
needs to be developed (Sampath, 2009). Every stage, 
from the infection of host cells to the assembly of new 
virus particles, can be targeted in the development of the 
inhibitor molecule (drug design) that can inhibit the 
activity of replication enzymes of the dengue virus, such 
as the enzyme protease, RdRP, methyltransferase and 
helicase (Kirsten, 2008).  
A peptide that has the α-keto amide bond in its amides 
can act as a competitive inhibitor of the NS3 protease 
with a Ki value in the micro-molar region (Katzenmeier, 
2004). Some examples of nonstructural (NS) enzymes of 
the replication complex is a cofactor of NS2B-NS3 
protease, NS3 helicase / nucleoside triphosfatase 
(NTPase) / RNA 5 'triphosfatase (RTPase), and NS5 
methyltransferase / RNA-dependent RNA polymerase 
(RdRp). These proteins can be used as potential inhibitor 
targets for antiviral agents during virus replication 
(Tomlinson et al., 2009). NS3 protease enzymes are the 
primary targets for the development of antiviral drugs 
since dengue NS2B-NS3 protease is required for viral 
replication (Othman et al., 2007). NS3 protease's active 
sides are at residues His51, Asp75 and Ser135. NS3 
protease enzyme requires NS2B as a cofactor to activate 
the protease enzyme (Qi et al., 2007). The 3D peptide 
database content has expanded the role of computational 
high throughput screening (HTS) in the search for 
dengue antiviral drug (Tomlinson et al., 2009). There are 
many computational studies that have been carried out 
by identifying the corresponding protein targets, and 
designing an inhibitor that can interact with the target 
protein in order to block the normal function of the target 
(Singh, 2006). The studies of genomics and proteomics 
have facilitated the discovery of new targets for drug 
design (Alonso et al., 2006). Molecular modeling is a 
technique for designing and displaying the structure and 
properties of certain molecules by using computational 
chemistry and graphical visualization techniques (Leach, 
2001). Computational methods in drug design was utlized 
because it is more rational and efficient (Tomlinson et al., 
2009). Molecular modeling techniques include molecular 
docking and molecular dynamics. According to Nurbaiti 
(2009), in his research, biomolecules such as proteins 
and nucleic acids is a dynamic system.  
Research conducted by Yin (2005) aimed to find NS3 
protease inhibitors that are potent and selective based on 
the evaluation of the synthesis of tetra peptide sequence 
of linear aldehyde. Synthesis of the evaluation results 
showed that the shape inhibitor Bz-Lys-Arg-NLE-Arg-H 
(Ki 5.8 μM)  is  the  best inhibitor and is  active in  dengue  
 
 
 
 
virus NS3 protease. Research carried out by Tambunan  
et al. (2009, 2010) on NS3-NS2B protease inhibitors 
showed that cylic pentapeptide are indeed feasible for 
inhibitors. Thus, it is possible to study the effect of solvent 
molecules in protein structures (Alonso et al., 2006). 
However, the decision to pick tripeptide as the research 
object was chosen due to the previous study of our group 
(Jois et al., 1996) 
The purpose of this research was to study the inter-
actions and conformations of the seven tripeptide poten-
tial inhibitors with dengue NS2B-NS3 protease virus type 
2 in the hydrated state using the method of molecular 
dynamics simulations. In addition, this study also eva-
luates and determines potential ligands to be developed 
as a drug. 
 
 
MATERIALS AND METHODS 
 
Following the study of Usman et al. (2011, 2010), this study’s 
methodology was divided into two parts: the molecular docking and 
dynamics session. 
 
 
3D Structure of dengue virus NS2B-NS3 protease 
 
Complex three-dimensional structure of the NS2B-NS3 protease 
dengue virus was obtained from the database of Protein Data Bank 
(PDB) with the specific enzyme ID 2FOM 
(http://www.rcsb.org/pdb/). 
 
 
The active visualization of NS2B-NS3 protease 
 
Visualization of the active dengue virus NS3 protease and the 
location of NS2B as cofactor was done by using MOE2008.10 
software. 
 
 
Geometry optimization and energy minimization of the three 
dimensional structure of NS2B-NS3 protease 
 
The process of geometry optimization and energy minimization of 
NS2B-NS3 protease was made by removing water molecules and 
chlorine ions. Furthermore, protonation with protonate 3D was done 
to change the state into the ionization level.  
 
 
Design of three dimensional structure of cyclical peptide 
inhibitors 
 
At this stage, ACDlabs software was used to design the cyclic 
peptide amino acid sequences into 3D structure. Cyclic peptides 
modeled with each end of the cysteine residues were added to form 
disulfide bridges and proline bond to yield a cyclic peptide based on 
the proline-proline bridge. Furthermore, the model peptide was 
conditioned in a state of zwitter ion. 
 
 
Geometry optimization and energy minimization of the three 
dimensional structure of cyclical peptide  
 
Cyclic peptide optimization was carried out on the MOE database 
viewer (dv). The optimization process begins with 'wash' process for  
 
 
 
 
the entire cyclic peptide. Then, the partial charge was applied with 
MMFF94 method. 
 
 
Molecular docking 
 
Molecular docking process was done using the MOE 2008.10 
software through the MOE-dock program. Placement methods used 
are matcher triangle with the 2500000 rounds. Scoring function 
used is the London dG, while the refinement was done using force 
field with the population of 1000 repetitions. The tripeptides were 
made in the restriction of the active residues. 
 
 
Ligand interactions at a temperature of 300 and 312 K 
 
Analysis of ligand interactions with the enzyme at temperatures of 
312 K as well as the analysis of ligand interactions at 300 K was 
done by LigX ligand Interaction option in the MOE 2008.10 
software. 
 
 
Enzyme-ligand complex conformation of the molecular 
dynamic results 
 
In the initialization phase, the observations were taken every 10 ps, 
then the heating stage was conducted every 10 ps, equilibration 
stage of 500 ps, and cooling stages of 5 ps.  
 
 
RESULTS AND DISCUSSION 
 
3D Structure of dengue virus NS2B-NS3 protease  
 
The selection of the specific PDB code 2FOM is based 
on the structure of the NS3 protease interactions with 
NS2B as a cofactor, though 2FOM is the only PDB code 
of NS2B-NS3 protease derived from dengue virus type 2 
(Erbel et al., 2006). 
 
 
Visualization of active NS3 protease and NS2B 
cofactor 
 
NS3 serine protease has active sides in the three 
functional amino acid, namely His51, Asp75 and Ser135 
(Wichapong et al., 2009). These three amino acids are 
present in the enzyme binding site and has polar and 
hydrophilic properties. NS2B-NS3 protease has a rela-
tively flat binding site (Erbel et al., 2006). This active site 
has a negatively charged region around Asp75 and 
Ser135. Moreover, these enzymes prefer substrates that 
have a positive residual group (Noble et al., 2010). 
Visualization results of three active side residues can be 
done using MOE 2008.10 software, and its interaction 
with the cofactor is shown in Figure 1. The far distance of 
NS2B from the active side showed that the cofactor does 
not contribute directly to the enzyme catalytic reaction, 
but plays an important role in enzyme catalytic activity 
(Lescar et al., 2008).  The active form of protease can 
occur if the cofactor NS2B hydrophilic 49 to 95 amino 
acid residues interact with the NS3 protease through nine  
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residues connecting flexible Gly4-Ser-Gly4 (Lescar et al., 
2008; Leung et al., 2001). The data were adopted from in 
vitro studies by Yusof et al. (2000). Research conducted 
by Erbel et al. (2006) reveals that the productive confor-
mation of the NS2B-NS3 protease in the catalytic process 
makes this enzyme an important target in drug discovery. 
NS2B-NS3 protease chymotrypsin fold adopted a 
conformation of two β-barrel that surrounds the three 
active sides. Each β-barrel is formed by six β-strands 
(Bollati et al., 2010). Therefore, these forms can protect 
hydrophobic residues from the solvent and provide 
stability to the protease (Lescar et al., 2008; Erbel et al., 
2006). In addition, amino acid residues Arg78-Leu87 of 
NS2B cofactor also influences the active side formation 
of the β-hairpin that was inserted into the end of the C-
terminal β-barrel. In this end, more active side residues 
concentrate on the introduction of the substrate (Lescar 
et al., 2008). 
 
 
Geometry optimization and energy minimization of 
the 3D structure of NS2B-NS3 protease 
 
The protonation of NS2B-NS3 protease complex is 
carried out with the program protonate3D of MOE 
2008.10 software. This process was done to condition the 
enzyme in the protonated state (Tambunan et al., 2010). 
In the next phase, the addition of the enzyme complex 
loads (partial charge) using the current method of force 
field parameters was done. The last stage of the process 
of geometry optimization and minimization of enzymes is 
energy minimization using the software MOE 2008.10. 
Energy minimization can eliminate undesirable inter-
actions (bad contact) of a structure (Nurbaiti, 2009). Use 
of force field MMFF94x is considered better than the 
other force field due to a better sensitivity to the geometry 
optimization of protein (enzyme) with the inhibitor 
(Tambunan et al., 2010). Energy minimization process 
was done by the RMS gradient 0.05 kcal / Å corres-
ponding to the protein. Other parameters in the energy 
minimization process were done using the default 
standard of MOE2008.10. 
 
 
Molecular docking 
 
The selected seven ligands were performed with 
molecular docking processes; these include the standard 
ligand Bz-Lys-Arg-NLE-Arg-H, ligand KRK, RGR, KKR, 
RKK, RRA and RKR. They were performed to dock with 
the three sides of the enzyme active NS3 protease of 
His51, Asp75 and Ser135. The scoring functions in MOE 
2008.10 software is based on the function of force-field 
scoring. This function takes into account the ligand-
receptor interaction energy and ligand internal energy 
(Nylander, 2007). In this study, the utlized scoring 
function is the London dG. This scoring function estimates 
the Gibbs free energy of binding (ΔGbinding) by posing a 
ligand to an enzyme (Vilar et al., 2008). Triangle matcher 
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Figure 1. Visualization of the active NS3 protease and NS2B cofactor. 
 
 
 
Table 1. The results of molecular docking. 
 
Ligand ΔGbinding ( kkal/mol) pKi Log P 
Cyclic (-Cys-RKR-Cys-) -16.493 12.231 -4.110 
Cyclic (-Cys-RRA-Cys-) -15.417 11.246 -3.721 
Cyclic (-Cys-KRK-Cys-) -14.436 10.864 -2.746 
Cyclic (-Cys-RGR-Cys-) -12.549 9.977 -4.110 
Cyclic (-Pro-RKK-Pro-) -12.209 9.121 -2.042 
Cyclic (-Pro-KKR-Pro-) -12.182 8.645 -2.042 
Bz-Nle-Lys-Arg-Arg-H -10.467 7.940 -0.716 
 
 
 
is used to orient the ligand in the active side groups 
based on the charge and spatial fit to produce an optimal 
bonding orientation. The force field utilized the 
Generalized Born model of solvation on the stage of final 
energy evaluation while GridMIn uses electrostatic 
calculations on the minimization process (Villar et al., 
2008). 
 
 
Analysis of molecular docking 
 
The molecular docking process data are shown in Table 
1. Display of residual interactions and hydrogen bonding 
contacts between the ligand and the enzyme is shown in 
Figure 2. The data of the interaction of residue contacts 
and hydrogen bonding are shown in Table 2. In Table 1, it 
is shown that the ΔGbinding values are negative indicating 
that a complex between the ligand and the enzyme can 
be formed. RKR ligands in the table have the greatest 
value of ΔGbinding (-16.493 kcal/mol) when compared with 
the other six ligands. In contrast, the standard ligand 
produces the smallest value of ΔGbinding (-10.467 
kcal/mol). This indicates that the ligand bound RKR is the 
most powerful among the other six ligands. Table 2 on the 
block letters indicate the active residues of the NS3 
protease. Overall, the data shows that the molecular 
docking of ligands formed seven interaction with the 
enzyme active NS3 protease. As shown in Figure 2, the 
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Table 2. Interaction results of molecular docking. 
  
Ligand Contact residue Hydrogen bond 
(-Cys-RKR-Cys-) 
Trp50, Val52, Asp75, Pro132, Gly133, His51, 
Lys73, Asn152, Gly153, Val162, Val154, Tyr161, 
Leu128 
Val52, Asp75, His51, Lys73, 
Asn152, Gly153, Val154, Val162 
   
(-Cys-RRA-Cys-) 
Pro132, His51, Gly153, Asn152, Lys73, Asp75, 
Val72, Trp50, Arg54 
Pro132, His51, Gly153, Lys73, 
Asp75, Val72, Trp50, Arg54 
   
(-Cys-KRK-Cys-) 
Arg54, Asp75, Gly153, Asn152, Leu128, Ser135, 
Tyr150, Gly151, Pro132, His51, Gly133, Val52, 
Ile36 
Arg54, Asp75, Gly153, Asn152, 
Tyr150, Pro132, His51, Val52, 
Ile36  
   
(-Cys-RGR-Cys-) 
Gln35, Glu92, Ile36, Pro132, Val52, His51, Arg54, 
Asp75, Asn152, Gly153 
Gln35, Val52, His51, Arg54, 
Asp75,  
(-Pro-RKK-Pro-) 
Val52, His51, Leu128, Ser163, Gly151, Asn152, 
Asp75, Gly153, Lys74, Lys73, Val72 
Val52, His51, Gly151, Asn152, 
Gly153, Lys73, Val72 
   
(-Pro-KKR-Pro-) 
Val72, Asp75, Asn152, Trp50, Gly153, His51, 
Ile36, Pro132, Gly133 
Val72, Asp75, Asn152, Gly153, 
His51, Ile36, Pro132,  
   
Bz-Nle-Lys-Arg-Arg-H 
Arg54, Asp75, Val52, Ile36, His51, Gly133, Gln27, 
Ser135, Pro132, Gly153, Asn152 
Asp75, Ile36, His51, Gln27, 
Pro132, Gly153 
 
Bold: Active site residues that facilitate hydrogen bonding with the ligand. 
 
 
  
a)
 
b)
 
 
 
 
c)
 
 
 
 
d)
 
e)             f)         
 
 
 
 
 
Figure 2. Results of residue contacts ligand docking: (a) Standard ligand, (b) RKK ligand, (c) KKR ligand, (d) ligand 
RGR; (e) ligand KRK; (f) ligand RRA; (g) ligand RKR. 
 
 
 
visualization of RKR data on the ligands can form two 
hydrogen bonds to the active side residues Asp75 and 
two hydrogen bonds to the His51 residue, while the 
ligand  RRA  only forms  a  hydrogen  bond  to the  Asp75  
residue and two hydrogen bonds to the His51 residue 
(Tambunan et al, 2010; Nurbaiti, 2009). Table 1 also con-
sist of log P values for the seven ligands. From Table 1, it 
is shown that the design of cyclic peptides has a nega-
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tive log P value. Based on the data in Tables 1 and 2, the 
molecular docking of ligand candidates has produced 
seven RKRs as the best ligands. They are based on the 
value of ΔGbinding -16.493 kcal/mol and the p Ki of 12.231. 
Those values are considered the best when compared 
with the seven other ligands.  
 
 
Molecular dynamics simulations  
 
Molecular dynamics simulations were performed using 
the software program of dynamic MOE.2008.10. This 
process uses Nosé-Poincaré-Andersen (NPA) algorithm 
that can be properly ensembled, and ensure that the 
trajectory is generated according to the desired 
thermodynamic conditions. The whole stage setting was 
done on the potential parameter setup software contained 
in MOE.2008.10 (Alonso et al., 2006). The force field 
utilized MMFF94x and NVT (N=constant number, 
V=volume, and T=temperature) ensemble, and a pres-
sure of 101 kPa. According to Tambunan et al. (2010), 
force field MMFF94x can put hydrogen atoms on the 
most appropriate position. In addition, the pocket is also 
set at a cutoff of 6 Å. The system begins with the initiali-
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zation phase. Initialization molecules include the determi-
nation of the position and initial velocity of the molecules. 
At this stage of initialization, simulations were performed 
for 50 ps; correlation plot can be seen in Figure 3. From 
these images, it can be observed that at 50 ps, the 
potential energy of the system tends to be stable and it 
was chosen as the initial stage of the primary simulation 
for 5000 ps. Furthermore, the main stage during the 5000 
ps simulations was performed at the temperatures of 300 
K and 312 K. 
 
 
Molecular dynamics simulations at 300 K 
temperature 
 
Temperature of 300 K was chosen because it is a room 
temperature. The time setting was adjusted at dynamics 
box column with the run process for 5000 ps. The cooling 
stage performed for 20 ps until the simulation increased 
to a temperature of 1 K. Then, the tool box for the data 
storage was selected for position, velocity, and 
acceleration in every 0.5 ps. 
 
 
Molecular dynamics simulation on the temperature of 
312 K 
 
Temperature  of  312 K was  chosen  on the grounds  that  
the condition is the same as the temperature of a person 
who has dengue fever (Tambunan et al., 2009). Heating 
stage process was done to raise the temperature of the 
system towards a state of equilibrium stage. The equi-
librium state is where the density of distribution of the 
atomic positions in all the systems that provide relaxed 
conditions on the molecule is restrained when the system 
is heated (Tambunan et al, 2010; Nurbaiti, 2009). Accor-
ding to Sharma et al. (2009), obtained trajectory is formed 
by recording the coordinates of the various structural 
changes within a certain time scale showing the position 
of each atom. 
 
 
Analysis of molecular dynamics simulation 
 
The molecular dynamics simulation was performed with a 
5 ns time scale. The treatment time of 5 ns was adopted 
from studies conducted by Nurbaiti (2009) and Tambunan 
(2010) which suggest that the molecular dynamics 
simulation was performed on a nanosecond time scale 
(10
-9
). In the initialization phase, the six frames were 
observed in every 10 ps simulation. To obtain a heating 
process, three frames was observed every 10 ps. On the 
main stage of the simulation, the observations were made 
every 500 ps which produces 11 frames of a conforma-
tional change. For the cooling phase, five frames were 
observed every 5 ps. Observations on the conformational
4426        Afr. J. Biotechnol. 
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Figure 3. Correlation plot of the initialization parameter determination.  
 
 
 
changes are also done through the root-mean-square 
deviation (RMSD) values. It is observed as an indication 
of the degree of change in backbone conformational 
changes in the structure of the simulation time. The triplo 
dynamics computation has been applied, and no signi-
ficant change in free energy could be found. 
 
 
Analysis of ligand interactions 
 
Molecular dynamics simulations at 300 K 
temperature 
 
Interactions change during the simulation at a tem-
perature of 300 K is shown in Table 1 of online supple-
mentary material (spl mtr). Observations of KKR ligands 
at 1000 ps do not show hydrogen bonding with the active 
side. Similarly, ligand RKK, observed at 1500, 2000, 
3000, 3500, 4000 and 4500 ps indicates the absence of 
hydrogen bonds formed on the active side residues. 
Therefore, the two ligands are not feasible to use as an 
inhibitor of the protease complex NS2B-NS3 dengue 
virus. RGR and KRK ligand which is a ligand-based cyclic 
disulfide bridge, at the end of the simulation is observed 
to interact with Asp75 which is the active side residue. 
Ligand RGR did not record any interaction of hydrogen 
bonds at the time of 2500, 3000 and 4500 ps. So, the 
inhibition ability decreased in that time interval. 
Nonetheless, it is with KRK ligand that the ligand 
recorded a release of hydrogen bonding on the active 
side at an interval of 1500, 3500, 4000 and 4500 ps. 
Thus, ligands RGR and RRA did not have the consis-
tency of affinity towards the active side residues. So, it 
may not be filed as an inhibitor for drug development. 
Observation of the ligand and the RKR and RRA that are 
also ligand-based cyclic disulfide bridges were found to 
have the best affinity ligand than the other five. Based on 
the molecular dynamics simulations at temperatures of 
300 K, the generated data of ligand RRA and RKR had a 
good affinity to the enzyme’s active site. 3D visualization 
of the RRA and RKR ligand at the end of the simulation 
can be seen in Figure 4. From these images, it can be 
seen clearly that the RRA ligand can interact with the 
active side residues of Asp75 through three hydrogen 
bonds with each bond length 1.71, 1.50, and 1.86 Å. This 
case also occurred in RKR ligand that has two hydrogen 
bonds with Asp75 residue, having bond length of 1.65 
and 1.62 Å, respectively. Table 1 (spl mtr) also demon-
strates the interaction between the ligand and several 
other amino acid residues, which include Asp129. Amino 
acid residue Asp129 is recorded as having hydrogen 
bonding interactions with side chains of the ligand’s 
amino acids arginine. Asp129 is an alkaline amino acid, 
so it fits with alkaline arginine and lysine as well. This is 
consistent with that proposed by Li et al. (2005) that 
amino acid Asp129 plays an important role in stabilizing 
amino acids such as arginine and lysine in the ligand. In 
fact, the ligand RRA and RKR recorded the greatest
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Figure 4. Visualization of 3D simulation of hydrogen bonds at a temperature of 300 K: (a) Ligand RRA; (b) Ligand RKR. 
 
 
 
number of contacts with the Asp129 residue of the 
protease. This indicates that the ligand is suitable and 
stable on the active side of the NS3 protease of dengue 
virus. 
Conformation can be seen from its frame at each time 
interval. RMSD results will be plotted in a graph between 
the RMSD and the simulation time. Conformation of the 
seven ligands at the time of the simulation is shown in 
Table 2 (spl mtr).  In a study presented by Zuo et al. 
(2009), the residues of the active NS3 protease domain is 
divided into two parts. Domain I consists of amino acids 
Asp75 and His51, while the second domain consists of 
amino acids Ser135. The presence of NS2B as a cofactor 
of the NS2 protease will surround the area, especially on 
the active side. In Figure 4, the area circled in red shows 
that the active or binding site is shaped like a slit. RMSD 
values in Table 3 indicate that there is a position shift of 
the conformation at the end of the simulation with the 
initial position. Free enzyme conformations have the 
largest shift value when compared with the complex 
formed between the ligand and the enzyme. Therefore, 
we can conclude that the presence of inhibitors in com-
plex NS2B-NS3 protease can enhance the stability of 
conformations. 
 
 
Molecular dynamics simulation on the temperature of 
312 K 
 
Molecular dynamics simulations were performed at a 
temperature of 312 K to see the affinity of the ligand to 
the active enzyme under conditions of fever. Changes in 
the interaction between the ligand and the enzyme were 
observed to obtain the best ligand affinity. Table 3 (spl 
mtr) shows the interaction of the ligand in the form of 
residue contacts and hydrogen bonds for molecular 
dynamics simulations at a temperature of 312 K. The 
treatment was performed for the system to represent the 
temperature at the time of fever. In Table 3 (spl mtr), the 
data obtained from the different interactions are gene-
rated through the simulation at a temperature of 300 K. 
Overall, all ligands (except the standard ligand) can 
interact with the enzyme active site through contact 
residues and hydrogen bonds at the end of the simu0-
lation. This simulation also produces a conformational 
change that can be observed in Table 4 (spl mtr).  
Significant changes occur when the complex is treated 
by raising the temperature of the system from 300 K to 
312 K. Thus, the observation of the complex interactions 
between the ligand is able to provide information to study 
the affinity of an inhibitor.In Table 4 (spl mtr), it can be 
observed from the cleft position that the enzyme binding 
site area was formed during the simulation in progress. In 
Table 4, it is also shown that the ligand RRA and RKR at 
the end of the simulation bound to the binding site area. 
However, this position is covered by the conformation of 
the formed enzyme.  
Thus, the catalytic function of the en-zymes is lost. 
Observations on the ligand KKR, RKK, RGR and KRK 
also showed that the ligand binding area remained on the 
site of NS2B-NS3 protease complex. In general, the 
conformation of the enzyme complex formed between the  
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Table 3. RMSD in the simulation with the 
temperature of 300 K. 
 
Ligand RMSD (Å) 
Free Enzyme 18.816 
Cyclic (-Cys-RKR-Cys-) 14.357 
Cyclic (-Cys-RRA-Cys-) 12.294 
Cyclic (-Cys-KRK-Cys-) 11.227 
Cyclic (-Cys-RGR-Cys-) 11.196 
Cyclic (-Pro-RKK-Pro-) 12.516 
Cyclic (-Pro-KKR-Pro-) 11.743 
Bz-Nle-Lys-Arg-Arg-H 13.358 
 
 
 
inhibitor always changes during the simulation. This 
change is also indicated by the RMSD values in Table 4. 
From Table 4, significant differences can be seen when 
compared with the RMSD values on the simulation with 
the temperature of 300 K. On the free-enzyme state, a 
decline in the value of RMSD from 18.816 Å to 14.243 Å 
was noted. However, this case is different from what 
happened in the other six ligands.  
The six ligands are likely to experience changes that 
increase the value of RMSD. The ligand conformation of 
RKR and RRA is fitted into the slit on the enzyme, 
resulting in an enzyme binding site which is also bent into 
the catalytic site. Visualization of the active conformation 
of the ligand, and the RRA and RKR molecular dynamics 
simulation results at a temperature of 312 K can also be 
observed in Figure 5. In Figure 5, it is observed that the 
RRA ligands can form three hydrogen bonds with 
residues Asp75 to the active side. The bond lengths are 
1.54, 1.70, and 1.90 Å, respectively. While the 
visualization of the RKR ligand was observed, it has four 
hydrogen bonds each with the lengths of 1.53, 1.60, 1.81 
and 1.93 Å, respectively. It can be concluded that the 
RKR ligand interaction with the active site of NS3 
protease in molecular dynamics simulations with a tem-
perature of 312 K was the best. This is because the RKR 
ligand is the most capable of forming hydrogen bonds 
when compared with most of the  
other ligands. 
 
 
Combination of molecular docking and molecular 
dynamics simulation 
 
In this study, both docking and dynamics methods are 
combined to see the interaction between the ligand as an 
inhibitor to the enzyme complex. This combination pro-
duces a data comparison of the interaction between the 
ligand during docking and dynamics simulation in Table 4.  
From Table 4, it can be observed that the standard 
ligand docking process has a hydrogen bond with the 
active side residues Asp75, His51 and Ser135. Obser-
vations at a temperature of 300 K and 312 K show that at  
 
 
 
 
Table 4. The RMSD values based on the 
simulation with a temperature of 312 K. 
 
Ligand RMSD (Å) 
Free Enzim 14.243 
Siklik (-Cys-RKR-Cys-) 17.446 
Siklik (-Cys-RRA-Cys-) 14.370 
Siklik (-Cys-KRK-Cys-) 17.624 
Siklik (-Cys-RGR-Cys-) 12.810 
Siklik (-Pro-RKK-Pro-) 15.446 
Siklik (-Pro-KKR-Pro-) 15.375 
Bz-Nle-Lys-Arg-Arg-H 13.354 
 
 
 
the end of the simulation, the standard ligand has lost its 
inhibition ability. Simulation at a temperature of 300 K for 
ligand RKR and RRA showed that the side chains of argi-
nine can interact with Asp75 residue. Similarly, the 
hydrogen bonding interaction is seen at a temperature of 
312 K, such that the arginine side chain can influence the 
formation of hydrogen bonds.  
In a study conducted by Wichapong et al. (2009), 
arginine and lysine residues are part of residue P2 which 
forms the inhibitor. This P2 residue would interact with the 
S2 pocket of the enzyme, including the active side 
residues of Asp75. For the P1 residue of the inhibitor, it is 
also proposed that the arginine plays an important role in 
the interaction with the S2 pocket, which is the active 
Ser135 residue.  
Lysine residues can also be selected as the P3 of the 
inhibitor to bind to the S3 pocket residues. The interaction 
between the inhibitor in the pocket P4 and S4 in the NS3 
protease is dominated by hydrophobic interactions such 
as Val154 and Val155 (Li et al., 2005). Further visua-
lization can be seen in Figure 6. RKK and KKR ligands 
that are cyclic proline-proline-based ligands also show 
that the hydrogen bond formed by residues Asp75 is a 
form of interaction of the side chains of arginine or lysine. 
Observation of the ligand and the RGR at both tem-
peratures showed that RRA form similar interactions with 
other ligands (Tambunan et al., 2010). 
The depiction of the seven ligands resulting from each 
process can be observed in Table 5 (spl mtr). The results 
of molecular docking processes compared with the 
molecular dynamics simulation at 300 and 312 K pro-
duced a difference in conformation of the enzyme com-
plex.  
It showed that the enzyme binding site area did not 
change as long as the simulation did not change. So it 
formed a cleft as the substrate binding site. However, the 
movement did not make the drug to be inactive towards 
the active side of the target (Tambunan et al., 2010). It 
was observed that at the end of the simulation, all the 
ligands except the standard one were able to interact with 
the active side residue of NS3 protease via hydrogen 
bonds.
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a) 
 
b) 
 
  
 
 
Figure 5. Visualization of 3D simulation of hydrogen bonds at a temperature of 312 K. (A) Ligand RRA; (b) Ligand RKR. 
 
 
 
Conclusion 
 
Based on studies using molecular dynamics simulation 
method, results were obtained that the interaction of the 
amino acid residues of NS2B-NS3 protease ligand of 
dengue virus type 2 is affected by the behavior of the 
dynamic movement of the enzyme-ligand complex. This 
dynamic movement occurs due to the influence of explicit 
solvent in the system. 
The influence of this dynamic movement, among 
others, are the residue contact interactions and hydrogen 
bonding between the ligand and the enzyme amino acid 
residues. This dynamic movement also influences the 
shape of conformations generated during the simulation. 
Molecular docking results showed seven residues of the 
ligand that can interact with the active enzyme. This 
process produces a ligand RKR in the top position with a 
minimum value of ΔGbinding and the largest PKi. Having 
performed molecular dynamics simulations, all ligands 
except the standard have an active side residue of NS3 
protease.  
However, the relatively stable ligands that bind to the 
active side are the RRA and RKR. At the end of the 
simulation temperature of 300 K, ligands RRA and RKR 
have hydrogen bonding contacts with Asp75. Then at the 
end of the simulation temperature of 312 K, ligands RKR 
and RRA also have hydrogen bonds with Asp75. There-
fore, the determination of the best ligand was done by 
reviewing the value of ΔGbinding molecular docking results. 
Standard ligand linear conformation was not stable to 
attach to the binding site area when compared with other 
cyclic ligands. This is evident from the shift experienced 
by the ligand conformation standard of the binding site 
area during the simulation. RKR ligand conformation was 
observed to have the most suitable form of the binding 
site area. Conformations that are formed in the enzyme-
inhibitor complex also changes during the simulation. 
RKR has the conformation of the ligand due to the 
suitability of the alkaline side chain structure that is 
appropriate for a negatively charged cleft (oxyanion hole). 
Based on the analysis of ligand interactions and confor-
mation, the ligand affinity RKR is the best compared to 
other ligands. 
 Thus, the combination of molecular docking methods 
and molecular dynamics simulation produces the best 
RKR ligand that has potential to be developed as a drug. 
Further study needs to be conducted on the absorption, 
distribution, metabolism, excretion, and toxi-city (ADMET) 
of ligands proposed as a drug as well as considering the 
possibility of a mutation in the enzyme due to binding of 
the ligand. 
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Table 5. Interaction of the ligand amino acid residues with molecular docking and molecular dynamics simulation at a temperature of 300 K 
and 312 K. 
 
Ligand Docking result 300 K 312 K 
RKR 
 
 
Trp50, Val52, Asp75, Pro132, 
Gly133, His51, Lys73, Asn152, 
Gly153, Val162, Val154, Tyr161, 
Leu128 
Tyr79, Asp75, Asp129, Ser78, 
Leu128, Phe130, Ala38, Ser131, 
Val40, Gly43  
Leu115, Phe116, Thr118, Thr48, 
Asp71, Asp75, Pro67, Val72, 
Lys74, Gly82, Trp83 
    
RRA 
 
Pro132, His51, Gly153, Asn152, 
Lys73, Asp75, Val72, Trp50, Arg54 
Trp83, Gly82, Gly81, Gly151, 
Asp129, Tyr79, Asp75, Tyr150, 
Ser78, Ile139, Ser127, Leu128 
Thr45, Gly44, Phe46, Met49, 
His47, Val140, Asp141, Gly103, 
Val146, Lys142, Asp75 
    
KRK 
Arg54, Asp75, Gly153, Asn152, 
Leu128, Ser135, Tyr150, Gly151, 
Pro132, His51, Gly133, Val52, Ile36 
Glu66, Asp71, Asp75, Tro50, 
Lys74, Arg54, Val52, Val72, Gly55 
Trp61, Ala65, Glu48, Ser71, 
Gly69, Ala49, Ser70, Leu74, 
Pro67, Trp69, Ser68, Glu66, 
Arg64, Asp75, Leu76, Asp71, 
Trp50, Arg54, Glu66 
    
RGR 
Gln35, Glu92, Ile36, Pro132, Val52, 
His51, Arg54, Asp75, Asn152, 
Gly153 
Asp75, Trp50, Glu66, Leu76, Ile77 
Ser158, Val154, His51, Trp50, 
Tyr79, Asp75, Leu76, Arg54  
    
RKK 
Val52, His51, Leu128, Ser163, 
Gly151, Asn152, Asp75, Gly153, 
Lys74, Lys73, Val72 
His47, Phe46, Gly39, Ala38, 
Leu149, Asn152, Tyr150, Ser135, 
Asp129 
Asp75, Gly153, Asn152, Gln93, 
Gly96, Tyr161, Gly37, Ile36, 
Ser158, Val155, Arg157, Ser78 
    
KKR 
Val72, Asp75, Asn152, Trp50, 
Gly153, His51, Ile36, Pro132, 
Gly133 
Asn152, Asn119, Thr122, Tyr79, 
Asp75, Ser78 
Asp75, Tyr79, Gly148, Asp129, 
Ser131, Met49, Ser131, Pro132, 
Ser135, His47, Val147, Tyr79 
 
Standar 
 
Arg54, Asp75, Val52, Ile36, His51, 
Gly133, Gln27, Ser135, Pro132, 
Gly153, Asn152 
 
Lys104, Gly103, Ser131, Gln110, 
Ser127, Ser70, Arg107, Ser68, 
Pro106, Phe130 
 
Glu90, Lys28, Ser85, Ile86, 
Glu101, Glu89, Gln27 
 
Bold, Amino acid residues that facilitate hydrogen bonding with the ligand; Bold, active site residues that facilitate hydrogen bonding with the 
ligand. 
 
 
 
 
 
Figure 6. Visualization of interaction between P (ligand) and S (enzyme) 
(Wichapong et al., 2009). 
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